chr20-38213602-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_001029864.2(KIAA1755):c.3043G>A(p.Ala1015Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000069 in 1,609,796 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_001029864.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KIAA1755 | NM_001029864.2 | c.3043G>A | p.Ala1015Thr | missense_variant | 14/14 | ENST00000279024.9 | NP_001025035.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KIAA1755 | ENST00000279024.9 | c.3043G>A | p.Ala1015Thr | missense_variant | 14/14 | 5 | NM_001029864.2 | ENSP00000279024.4 | ||
KIAA1755 | ENST00000460881.5 | n.1219G>A | non_coding_transcript_exon_variant | 3/3 | 1 | |||||
KIAA1755 | ENST00000487506.1 | n.995G>A | non_coding_transcript_exon_variant | 2/2 | 1 | |||||
KIAA1755 | ENST00000484362.1 | n.1322G>A | non_coding_transcript_exon_variant | 5/5 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152214Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000608 AC: 15AN: 246800Hom.: 0 AF XY: 0.0000523 AC XY: 7AN XY: 133950
GnomAD4 exome AF: 0.0000707 AC: 103AN: 1457464Hom.: 0 Cov.: 33 AF XY: 0.0000690 AC XY: 50AN XY: 724622
GnomAD4 genome AF: 0.0000525 AC: 8AN: 152332Hom.: 0 Cov.: 32 AF XY: 0.0000537 AC XY: 4AN XY: 74492
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 06, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at